Index by author

July 2019; Volume 39,Issue 7

Special Issue on New Anticancer Agents

  1. Alampi, DESIRÈ M.

    1. AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
      DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO
      Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529

  2. Althini, CARL

    1. The Role of PEDF in Pancreatic Cancer
      DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
    2. The Hippo Signaling Pathway in Pancreatic Cancer
      DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474

  3. Amano, MANABU

    1. The Involvement of Pregnane X Receptor-regulated Pathways in the Antitumor Activity of Cisplatin
      MEGUMI YASUDA, SHUICHI KISHIMOTO, MANABU AMANO and SHOJI FUKUSHIMA
      Anticancer Research July 2019, 39 (7) 3601-3608; DOI: https://doi.org/10.21873/anticanres.13507

  4. Andersson, ROLAND

    1. The Role of PEDF in Pancreatic Cancer
      DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
    2. The Hippo Signaling Pathway in Pancreatic Cancer
      DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474

  5. Ansari, DANIEL

    1. The Role of PEDF in Pancreatic Cancer
      DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
    2. The Hippo Signaling Pathway in Pancreatic Cancer
      DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON
      Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474

  6. Aoki, ICHIO

    1. Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes
      DONIKA IVANOVA, ZHIVKO ZHELEV, SEVERINA SEMKOVA, ICHIO AOKI and RUMIANA BAKALOVA
      Anticancer Research July 2019, 39 (7) 3745-3755; DOI: https://doi.org/10.21873/anticanres.13523

  7. Arandelovic, SANDRA

    1. A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”
      MJRIAM CAPULA, CRISTINA CORNO, BTISSAME EL HASSOUNI, GIOVANNA LI PETRI, SANDRA ARANĐELOVIĆ and on Behalf of the EORTC PAMM Group
      Anticancer Research July 2019, 39 (7) 3413-3418; DOI: https://doi.org/10.21873/anticanres.13485

  8. Atagi, SHINJI

    1. Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?
      MOTOHIRO TAMIYA, AKIHIRO TAMIYA, HIDEKAZU SUZUKI, KAZUNORI MORIIZUMI, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, KEI KUNIMASA, MADOKA KIMURA, TAKAKO INOUE, HANAKO KUHARA, KAZUMI NISHINO, TOMONORI HIRASHIMA, SHINJI ATAGI, FUMIO IMAMURA and TORU KUMAGAI
      Anticancer Research July 2019, 39 (7) 3923-3929; DOI: https://doi.org/10.21873/anticanres.13544

  9. Bacher, HEINZ

    1. Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT – A Pilot Study
      JOVAN VUJIC, HELMUT SCHÖLLNAST, KATHARINA MARSONER, VALERIE WIENERROITHER, HEINZ BACHER, HANS-JÖRG MISCHINGER and PETER KORNPRAT
      Anticancer Research July 2019, 39 (7) 3847-3854; DOI: https://doi.org/10.21873/anticanres.13534

  10. Bae, SI HYUN

    1. Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma
      PIL SOO SUNG, KEUNGMO YANG, SI HYUN BAE, JUNG SUK OH, HO JONG CHUN, HEE CHUL NAM, JEONG WON JANG, JONG YOUNG CHOI and SEUNG KEW YOON
      Anticancer Research July 2019, 39 (7) 3909-3916; DOI: https://doi.org/10.21873/anticanres.13542
« Previous (Pages : 1 2 3 4 5 6 ... 48) Next »
Back to top

In this issue